ÂÜÀòÂÒÂ×

Paul Clewlow is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as a Non-Executive Director at Isogenica Limited and Opportunity Pharma Ltd, as well as a Director at Bright Angel Consultancy Ltd. Paul offers strategic commercial advice and has held various consultancy roles, including positions at CryoLogyx, Ignota Labs, and Pelago Bioscience AB. With a strong background in drug discovery, Paul was previously a Senior VP and Executive Board Director at Sygnature Discovery and contributed to RenaSci as a Board Director. Paul holds a PhD in Synthetic Organic Chemistry from Cardiff University and a BSc (Hons) in Chemistry from the University of Leicester, with additional education from Arizona State University, ETH Zürich, and Sir John Talbot's Grammar School.